Muscle News and Research

RSS

Surgery shows first-line potential for stress urinary incontinence

The authors of a head-to-head study say that surgery should be considered as a first-line option for women with stress urinary incontinence, ahead of physiotherapy.

23 Sep 2013

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) alone or in combination with methotrexate for the treatment of adult patients (18 years or older) with active psoriatic arthritis.

23 Sep 2013

Study: Messages coming from muscle receptors are enough to change the internal body representation

People can be easily tricked into believing an artificial finger is their own, shows a study published today [23 September] in The Journal of Physiology.

23 Sep 2013

HFSA’s Annual Scientific Meeting focuses on ways to prevent heart failure

The 17th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) will feature a session today entitled "The Prevention of Heart Failure." The session is being presented by HFSA and the American Heart Association.

23 Sep 2013

Sodium-potassium pump is pivotal to body's function

The story of the sodium-potassium pump has strong ties to Denmark. In 1997, the Danish scientist Jens Chr. Skou received the Nobel Prize in Chemistry for his discovery, and over the years, research on the pump has remained a strong focus area at Aarhus University.

23 Sep 2013

Falls are the leading cause of injuries in older populations

One of the top reasons for trauma admission at Vanderbilt University Medical Center may come as a surprise: falls.

23 Sep 2013

Falls can cause problems, but older adults can still maintain an active quality of life

A Saint Louis University School of Nursing faculty member is going to mark the first day of fall with a simple warning to senior adults: Don't let fear of falling stand in the way of being active and engaged with the world around you.

21 Sep 2013

PGI2 analogs, PDE5 inhibitors stimulate enhanced release of vasodilator ATP from human RBCs

Researchers at Saint Louis University School of Medicine have discovered a novel interaction between prostacyclin analogs and phosphodiesterase 5 inhibitors, two groups of drugs used in the treatment of pulmonary arterial hypertension.

21 Sep 2013

Phase III EINSTEIN trial program: XARELTO reduces risk of DVT and PE

Janssen Pharmaceuticals, Inc. announced today a newly published, pooled analysis of the Phase III EINSTEIN trial program, showing XARELTO (rivaroxaban) is as effective as the standard of care in reducing the risk of deep vein thrombosis and pulmonary embolism in people with symptomatic DVT or PE, while reducing the incidence of major bleeding by 46 percent.

21 Sep 2013

Older adults who gain little weight live longer

Some overweight older adults don't need to lose weight to extend their lives, but they could risk an earlier death if they pack on more pounds.

20 Sep 2013

Intentional weight loss can have positive health benefits in older adults

The medical community touts the importance of not carrying excess weight, but that has not always been the message delivered to older adults.

20 Sep 2013

WUSTL engineers apply new imaging technique to understand brain’s biomechanics

The human body has a lot of jobs to do, and its mechanical features, such as strength and flexibility, are important to how well it does them. Washington University in St. Louis engineers are now applying a new imaging technique to a model of brain tissue to see how stiff or soft it might be.

20 Sep 2013

Isis Pharmaceuticals announces preliminary data from ISIS-SMNRx Phase 1 study in infants with SMA

Isis Pharmaceuticals, Inc. announced today that follow-up preliminary data from a single dose, open-label Phase 1 study of ISIS-SMNRx in children with spinal muscular atrophy, show that most SMA children receiving the two highest doses of the drug (6 mg and 9 mg) continued to show improvements in muscle function tests up to 14 months after a single injection of the drug.

19 Sep 2013